期刊文献+

应用小分子肝素钙对过敏性紫癜并发远期肾损害干预效果的Meta分析

Effect of appling small molecule heparin calcium on long-term renal damage of patients with allergic purpura by Meta analysis
下载PDF
导出
摘要 目的应用Meta分析方法,评价小分子肝素钙对过敏性紫癜并发远期肾损害干预效果的。方法检索CNKI、万方、维普、CBM数据库及Cochrane图书馆,手工检索作为辅助,对纳入文献采取质量分析,采用Stata12.1软件行Meta分析。结果 4篇文献纳入随机对照临床试验(randomized controlled trials,RCT),样本共670例,其中333例小分子肝素钙治疗组(37例肾损害),337例对照组(44例肾损害),2组无明显差异(RR=0.89,95%CI:0.59-1.34,P=0.578)。结论早期应用小分子肝素钙可预防肾损害发生,但其远期干预效果并不明显,仍需通过多中心、大规模RCT做深入研究。 Objective To evaluate small molecule heparin allergic purpura complicated by long-term kidney damage intervention by Meta analysis.Methods Databases of CNKI,Wanfang,VIP,CBM and Cochrane Library were searched,hand searching as an auxiliary,included studies were assessed by quality of analysis,Meta-analysis was conducted by Stata12. 1 software line. Results 4 articles were included in randomized controlled clinical trials( randomized controlled trials,RCT),a sample of 670 cases,333 cases of small molecule heparin calcium treatment group( 37 cases of renal damage has occurred),337 cases of control group( 44 cases of renal damage has occurred),no difference between the 2 groups( RR = 0. 89,95% CI: 0. 59-1. 34,P = 0. 578). Conclusion The early application of small molecular weight heparin calcium can not prevent kidney damage,it needs to do in-depth research by multi-center,large-scale RCT.
作者 闫平 殷站茹
出处 《中国生化药物杂志》 CAS 2015年第9期177-179,共3页 Chinese Journal of Biochemical Pharmaceutics
基金 河北省衡水市科学技术研究与发展计划(13002Z)
关键词 小分子肝素钙 过敏性紫癜 肾损害 干预效果 META分析 small dose molecular heparin calcic Henoch-Schonlein purpura kidney damage intervention Meta analysis
  • 相关文献

参考文献10

  • 1吴挺柏,王婷,郑铠军,张静.低分子肝素钙对儿童过敏性紫癜早期肾损害的治疗效果评价[J].吉林医学,2014,35(13):2725-2726. 被引量:4
  • 2杨帆,张海玉,张影,李善玉.低分子肝素钙对儿童过敏性紫癜肾早期损害的治疗效果评价[J].吉林大学学报(医学版),2012,38(1):155-158. 被引量:14
  • 3张帆,张宝国,蒋海萍,唐荣,嵇志敏.低分子肝素钠预防过敏性紫癜肾炎机制研究[J].现代生物医学进展,2013,13(7):1345-1348. 被引量:5
  • 4厉红,郝冬荣,付辉,王兰英,岳爱红,杨晓莹,唐立敏.低分子肝素防治过敏性紫癜患儿肾损害53例[J].中国药业,2015,24(5):90-92. 被引量:6
  • 5Mollica F,Li Volti S,Carozzo R, et al. Effectiveness of early prednisoetreatment in preventing the development of nephropathy in anaphylactoidpurpura [J] . Eur J Pediatr, 1992 ,22( 151 ) : 140-144.
  • 6Saulsbury FT. Henoch-SchOnlein purpura [ J]. Curr Opin Rheumatol,2010,22(5) :598-602.
  • 7Huber AM,King J,McLaine P, et al. A randomized,placebo-controlledtrial of prednisone in early Henoch Schtinlein purpum [ J]. BMC Med,2004(2) :l-7.
  • 8Ronkainen J,Koskimies 0,Ala-Houhala M, et al. Early prednisonetherapy in Henoch一Sch6nlein purpura : a randomized, double-blind,placebo-controlled trial [ J ]. J Pediatr, 2006,149 ( 2 ) : 241-247.
  • 9Dudley J,Smith G,Llewellyn-Edwards A,et al. Randomised placebocontrolled trial to assess the role of early prednisolone on thedevelopment and progression of Henoch-Schonlein purpuranephritisf J]. Pediatr Nephrol, 2007 , 22(9) : 1457.
  • 10Jauhola 0,Ronkainen J,Koskimies 0,et al. Clinical course of extrarenalsymptoms in Henoch-Schonlein purpura : a 6-month prospectivestudy [J]. Arch Dis Child ,2010,95 (11) :871 -876.

二级参考文献40

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部